Who Owns LeMaitre Vascular Stock?
NASDAQ: LMATHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 11:36 AM ET
Ownership breakdown
- Held by institutions
- 103.91%
- Institutions (% of float)
- 111.16%
- Held by insiders
- 6.52%
- Institutional holders
- 442
- Institutions 93.5%
- Insiders 6.5%
- Public and other 0.0%
Who owns LeMaitre Vascular stock?
Institutional investors own about 103.9% of LeMaitre Vascular's shares, spread across 442 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 6.52% of LMAT.
The largest institutional holders are Blackrock Inc. (14.31%), Conestoga Capital Advisors, LLC (5.98%) and First Trust Advisors LP (4.78%). Together, the top 10 institutions control 50.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their LMAT positions and 3 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of LMAT
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 3.27M | 14.31% | +4.1% |
| Conestoga Capital Advisors, LLC | 1.37M | 5.98% | -7.4% |
| First Trust Advisors LP | 1.09M | 4.78% | +9.6% |
| Congress Asset Management Co | 961.51K | 4.20% | -0.2% |
| Vanguard Capital Management LLC | 953.44K | 4.17% | +4.5% |
| State Street Corporation | 901.42K | 3.94% | +5.3% |
| Copeland Capital Management, LLC | 839.46K | 3.67% | -3.6% |
| Geode Capital Management, LLC | 788.84K | 3.45% | +19.8% |
| Price (T.Rowe) Associates Inc | 755.14K | 3.30% | +156.0% |
| Vanguard Portfolio Management LLC | 604.83K | 2.64% | +7.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of LMAT
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 1.28M | 5.61% |
| First TRT Exch-Trd Fd. VI-First TRT SMID Cap Rising Dividend Achievers | 992.66K | 4.34% |
| Conestoga Funds-Conestoga Small Cap Fund | 869.02K | 3.80% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 690.81K | 3.02% |
| iShares Trust-iShares Russell 2000 ETF | 557.85K | 2.44% |
| Professionally Managed Portfolios-Congress Small Cap Growth Fund | 470.00K | 2.06% |
| T. ROWE PRICE QUANTITATIVE Mgmt Fd.S, INC.-T. Rowe Price Integrated U. | 404.85K | 1.77% |
| AIM Counselor Series TRT -Invesco Discovery Fd. | 286.67K | 1.25% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 241.13K | 1.05% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 238.65K | 1.04% |
Frequently asked questions
Who is the largest shareholder of LeMaitre Vascular?
Blackrock Inc. is the largest institutional shareholder of LMAT, owning 14.31% of shares outstanding (3.27M shares) as of its latest 13F filing.
What percentage of LeMaitre Vascular is owned by institutions?
Institutions own about 103.9% of LMAT shares and 111.2% of the public float.
How much of LeMaitre Vascular do insiders own?
Insiders, such as officers and directors, own about 6.52% of LMAT shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.